Nicola J Rose
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nicola J Rose has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
E. T. Mee
Division of Retrovirology, National Institute for Biological Standards and Control, Health Protection Agency, South Mimms, Hertfordshire, UK
2 shared publicationsK. Cutler
Division of Retrovirology, National Institute for Biological Standards and Control, South Mimms, Potters Bar, Hertfordshire, UK
2 shared publications- Neil Almond
National Institute for Biological Standards and Control
2 shared publications A. Cafaro
National AIDS Center, Istituto Superiore di Sanità, Rome, Italy
1 shared publicationA. Heath
Division of Biostatistics, National Institute for Biological Standards and Control, Hertfordshire, UK
1 shared publication- Alessandra Borsetti
National AIDS Center, Istituto Superiore di Sanità, Rome, Italy
1 shared publication
Latest Publications
- 12 April 2012
- Published by Wiley in Tissue Antigens
- Vol. 80 (1) , 36-45
Influence of MHC class I and II haplotypes on the experimental infection of Mauritian cynomolgus macaques with SHIVSF162P4cy
Mauritian cynomolgus macaques (MCM) are widely used in human immunodeficiency virus research because of their restricted major histocompatibility complex (MHC) diversity which provides the opportunity to address the influence of host factors on vaccine studies. We herein report the impact of MHC haplotype on the outcome of 21 MCM infections with the CCR5-tropic simian/human immunodeficiency virus (SHIV)SF162P4cy. MCM were susceptible to SHIVSF162P4cy infection as shown by viremia and loss of CD4+ T cells. A significant association between haplotype M7 (class IA, IB, II) and persistent viremia was observed in chronic phase, whereas recombinant class IA haplotype was associated with a reduction of viral RNA during acute infection. Class IB M4 haplotype displayed significantly lower acute phase provirus copy numbers. In addition, statistical analysis indicated a detrimental effect of haplotype M4 (class IA, IB) on the course of infection as indicated by lower CD4+ T-cell levels during chronic infection. A decrease in post-acute phase CD4+ T-cell numbers was also observed in haplotype M2 animals. This is the first report that documents the effects of host MHC class I and II molecules on the SHIVSF162P4cyinfection in MCM, particularly with regard to the association between recombinant class IA, M4, and M7 haplotypes and the dynamic of viral replication and level of CD4+ T cells.
- 12 April 2012
- Published by Wiley in Tissue Antigens
- Vol. 80 (1) , 36-45
Influence of MHC class I and II haplotypes on the experimental infection of Mauritian cynomolgus macaques with SHIVSF162P4cy
Mauritian cynomolgus macaques (MCM) are widely used in human immunodeficiency virus research because of their restricted major histocompatibility complex (MHC) diversity which provides the opportunity to address the influence of host factors on vaccine studies. We herein report the impact of MHC haplotype on the outcome of 21 MCM infections with the CCR5-tropic simian/human immunodeficiency virus (SHIV)SF162P4cy. MCM were susceptible to SHIVSF162P4cy infection as shown by viremia and loss of CD4+ T cells. A significant association between haplotype M7 (class IA, IB, II) and persistent viremia was observed in chronic phase, whereas recombinant class IA haplotype was associated with a reduction of viral RNA during acute infection. Class IB M4 haplotype displayed significantly lower acute phase provirus copy numbers. In addition, statistical analysis indicated a detrimental effect of haplotype M4 (class IA, IB) on the course of infection as indicated by lower CD4+ T-cell levels during chronic infection. A decrease in post-acute phase CD4+ T-cell numbers was also observed in haplotype M2 animals. This is the first report that documents the effects of host MHC class I and II molecules on the SHIVSF162P4cyinfection in MCM, particularly with regard to the association between recombinant class IA, M4, and M7 haplotypes and the dynamic of viral replication and level of CD4+ T cells.
- 19 May 2009
- Published by Wiley in Journal of Medical Primatology
- Vol. 38 (3) , 160-170
Low rates of transmission of SRV‐2 and STLV‐I to juveniles in a population of Macaca fascicularis facilitate establishment of specific retrovirus‐free colonies
Background Prevalence of simian retrovirus‐2 (SRV‐2) and simian T lymphotropic virus type I (STLV‐I), was unknown in 337 captive cynomolgus macaques.Methods and Results Molecular assays identified 29% of animals as SRV‐2 mono‐infected, 4% of animals as STLV‐I mono‐infected and 9% of animals as dual‐infected. Of 108 juvenile animals, 83% were SRV‐2‐negative and no juvenile animal was STLV‐I‐positive. A subsequent study of juvenile macaques over a period of 2.5 years detected no STLV‐I and 10 SRV‐2 infections, six of which occurred between testing and day of colony formation. The study also highlighted that an anti‐SRV‐2 serological response does not presuppose infection. Tissue reservoirs of latent SRV‐2 were not identified in suspected SRV‐2 infections.Conclusions Low transmissibility of the viruses present in the parental cohort and improved knowledge of the host response to SRV‐2 has facilitated the creation of specific‐retrovirus‐free colonies of cynomolgus macaques.
- 19 May 2009
- Published by Wiley in Journal of Medical Primatology
- Vol. 38 (3) , 160-170
Low rates of transmission of SRV‐2 and STLV‐I to juveniles in a population of Macaca fascicularis facilitate establishment of specific retrovirus‐free colonies
Background Prevalence of simian retrovirus‐2 (SRV‐2) and simian T lymphotropic virus type I (STLV‐I), was unknown in 337 captive cynomolgus macaques.Methods and Results Molecular assays identified 29% of animals as SRV‐2 mono‐infected, 4% of animals as STLV‐I mono‐infected and 9% of animals as dual‐infected. Of 108 juvenile animals, 83% were SRV‐2‐negative and no juvenile animal was STLV‐I‐positive. A subsequent study of juvenile macaques over a period of 2.5 years detected no STLV‐I and 10 SRV‐2 infections, six of which occurred between testing and day of colony formation. The study also highlighted that an anti‐SRV‐2 serological response does not presuppose infection. Tissue reservoirs of latent SRV‐2 were not identified in suspected SRV‐2 infections.Conclusions Low transmissibility of the viruses present in the parental cohort and improved knowledge of the host response to SRV‐2 has facilitated the creation of specific‐retrovirus‐free colonies of cynomolgus macaques.
- 12 September 2008
- Published by Wiley in Tissue Antigens
- Vol. 72 (4) , 369-378
The Mhc class II DRB genotype of Macaca fascicularis does not influence infection by simian retrovirus type 2
Simian retrovirus type 2 (SRV-2) is a natural pathogen of Macaca fascicularis. Although SRV-2 may be endemic in macaque colonies, it is not necessarily detected in all individuals suggesting differential susceptibility to SRV-2; factors contributing to this susceptibility are not fully understood. We have investigated the role of host genetic origin on virus susceptibility. We have shown that high levels of anti-SRV-2 antibodies correlate with failure to establish persistent virus infection, thus we targeted our genetic analysis of virus susceptibility with an investigation of the role of the polymorphic macaque major histocompatibility complex (MHC) class II locus. DRB genotypes, both novel and previously characterised, were identified in individuals and family groups. A discordance with SRV-2 infection status suggests that an Mhc II DRB genotype is not overtly associated with the outcome of viral infection.
- 12 September 2008
- Published by Wiley in Tissue Antigens
- Vol. 72 (4) , 369-378
The Mhc class II DRB genotype of Macaca fascicularis does not influence infection by simian retrovirus type 2
Simian retrovirus type 2 (SRV-2) is a natural pathogen of Macaca fascicularis. Although SRV-2 may be endemic in macaque colonies, it is not necessarily detected in all individuals suggesting differential susceptibility to SRV-2; factors contributing to this susceptibility are not fully understood. We have investigated the role of host genetic origin on virus susceptibility. We have shown that high levels of anti-SRV-2 antibodies correlate with failure to establish persistent virus infection, thus we targeted our genetic analysis of virus susceptibility with an investigation of the role of the polymorphic macaque major histocompatibility complex (MHC) class II locus. DRB genotypes, both novel and previously characterised, were identified in individuals and family groups. A discordance with SRV-2 infection status suggests that an Mhc II DRB genotype is not overtly associated with the outcome of viral infection.
- Open Access
- 1 January 2007
- Published by Springer Nature in Retrovirology
- Vol. 4 (1) , 24
Rapamycin-induced inhibition of HTLV-I LTR activity is rescued by c-Myb
Rapamycin is an immunosuppressive which represses translation of transcripts harbouring a polypyrimidine motif downstream of the mRNA cap site through the mammalian target of rapamycin complex. It inhibits the abnormal autologous proliferation of T-cell clones containing a transcriptionally active human T-lymphotropic virus, type I (HTLV-I) provirus, generated from infected subjects. We showed previously that this effect is independent of the polypyrimidine motifs in the viral long terminal repeat (LTR) R region suggesting that HTLV-I transcription, and not translation, is being affected. Here we studied whether rapamycin is having an effect on a specific transcription factor pathway. Further, we investigated whether mRNAs encoding transcription factors involved in HTLV-I transcriptional activation, specifically CREB, Ets and c-Myb, are implicated in the rapamycin-sensitivity of the HTLV-I LTR.
- 1 January 2007
- Published by Springer Nature in Retrovirology
- Vol. 4 (1) , 24
Open AccessRapamycin-induced inhibition of HTLV-I LTR activity is rescued by c-Myb
Rapamycin is an immunosuppressive which represses translation of transcripts harbouring a polypyrimidine motif downstream of the mRNA cap site through the mammalian target of rapamycin complex. It inhibits the abnormal autologous proliferation of T-cell clones containing a transcriptionally active human T-lymphotropic virus, type I (HTLV-I) provirus, generated from infected subjects. We showed previously that this effect is independent of the polypyrimidine motifs in the viral long terminal repeat (LTR) R region suggesting that HTLV-I transcription, and not translation, is being affected. Here we studied whether rapamycin is having an effect on a specific transcription factor pathway. Further, we investigated whether mRNAs encoding transcription factors involved in HTLV-I transcriptional activation, specifically CREB, Ets and c-Myb, are implicated in the rapamycin-sensitivity of the HTLV-I LTR.